A retrospective cohort study suggested that colchicine prophylaxis at urate-lowering therapy initiation may lower cardiovascular event risk in patients with gout.
This respiratory health update covers rising influenza deaths, the spread of new SARS-CoV-2 variants, shifting reinfection patterns, and cardiovascular risks in children
The FDA is seeking a cap on nicotine levels in cigarettes and certain tobacco products at minimally or nonaddictive levels. This initiative, if finalized, would be what the FDA calls a “significant step”...
A new study led by the Congenital Heart Initiative explores quality of life, mental health, and physical activity outcomes in a large cohort of adults with congenital heart disease.
In a study that assessed pericoronary adipose tissue (PCAT) density, researchers noted an association between higher PCAT density and greater coronary plaque burden and cardiovascular disease in people with...
A recent study found that non-dihydropyridine calcium channel blockers are associated with significantly less bradycardia during sinus rhythm compared with beta-blockers in patients with non-permanent...
Researchers developed a cohort study of more than 14,000 participants to determine whether there is an association between statin initiation and a reduced risk of mortality and major adverse cardiovascular...
On March 8, the FDA approved the injectable weight loss medication, semaglutide, for reducing the risk of cardiovascular events such as heart attack, stroke, and cardiovascular death in adults with heart...
Researchers conducted a systematic review to assess the effect of CPAP treatment for obstructive sleep apnea on secondary cardiovascular disease events.
Researchers set out to compare the time until the next treatment in patients with chronic lymphocytic leukemia who are treated with single-agent ibrutinib at a sustained dose of 420 mg/day vs patients who...
